tel XXX
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1601 - 1610 ee natiijooyinka 3563
Bixiye
QP52-21 Commercial and MHCP Pharmacy Benefit Exclusion for AduhelmTM
Taariikhda wax ku ool ah ee barnaamijka: Jun 23, 2021
Bixiye
QP53-21 Medical Drug Exclusion List Update – for Euflexxa
Taariikhda wax ku ool ah ee barnaamijka: Jun 23, 2021
Bixiye
QP2R1-21 Update for New to Market Medical Drugs: Aducanumab, Casimersen, Evinacumab, Idecabtagene Vicleucel, and Pegunigalsidase Alfa
Taariikhda wax ku ool ah ee barnaamijka: Jun 23, 2021
Bixiye
QP58-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Recorlev® (levoketoconazole)
Taariikhda dhaqangalka Barnaamijka: Jul 13, 2022
Bixiye
QP59-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Tarpeyo™ (budesonide)
Taariikhda dhaqangalka Barnaamijka: Jul 13, 2022